Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 240

1.

A phase II study of cetuximab, capecitabine and radiotherapy in neoadjuvant treatment of patients with locally advanced resectable rectal cancer.

Velenik V, Ocvirk J, Oblak I, Anderluh F.

Eur J Surg Oncol. 2010 Mar;36(3):244-50. doi: 10.1016/j.ejso.2009.12.002. Epub 2009 Dec 29.

PMID:
20042310
2.

Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study.

Velenik V, Ocvirk J, Music M, Bracko M, Anderluh F, Oblak I, Edhemovic I, Brecelj E, Kropivnik M, Omejc M.

Radiat Oncol. 2011 Aug 31;6:105. doi: 10.1186/1748-717X-6-105.

3.

Neoadjuvant chemoradiotherapy with capecitabine followed by laparoscopic resection in locally advanced tumors of middle and low rectum - toxicity and complications of the treatment.

Soumarova R, Skrovina M, Bartos J, Gruna J, Wendrinski A, Czudek S, Kycina R, Parvez J.

Eur J Surg Oncol. 2010 Mar;36(3):251-6. doi: 10.1016/j.ejso.2009.10.002. Epub 2009 Oct 30.

PMID:
19879716
4.

Effect of neoadjuvant cetuximab, capecitabine, and radiotherapy for locally advanced rectal cancer: results of a phase II study.

Sun PL, Li B, Ye QF.

Int J Colorectal Dis. 2012 Oct;27(10):1325-32. Epub 2012 Mar 20.

PMID:
22430888
5.

Pre-operative chemoradiotherapy with oral capecitabine in locally advanced, resectable rectal cancer.

Korkolis DP, Boskos CS, Plataniotis GD, Gontikakis E, Karaitianos IJ, Avgerinos K, Katopodi A, Xinopoulos D, Dimitroulopoulos D, Beroukas K, Vassilopoulos PP.

Anticancer Res. 2007 Jan-Feb;27(1B):541-5.

6.

Long-term results from a randomized phase II trial of neoadjuvant combined-modality therapy for locally advanced rectal cancer.

Velenik V, Oblak I, Anderluh F.

Radiat Oncol. 2010 Sep 29;5:88. doi: 10.1186/1748-717X-5-88.

7.

Preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with newly diagnosed, primary operable, cT₃NxM0, low rectal cancer: a phase II study.

Ofner D, Devries AF, Schaberl-Moser R, Greil R, Rabl H, Tschmelitsch J, Zitt M, Kapp KS, Fastner G, Keil F, Eisterer W, Jäger R, Offner F, Gnant M, Thaler J; TAKO 05/ABCSG R-02 Trial Investigators..

Strahlenther Onkol. 2011 Feb;187(2):100-7. doi: 10.1007/s00066-010-2182-6. Epub 2011 Jan 21.

PMID:
21267531
8.

A phase II trial of neoadjuvant capecitabine combined with hyperfractionated accelerated radiation therapy in locally advanced rectal cancer.

Marsh Rde W, George TJ, Siddiqui T, Mendenhall WM, Zlotecki RA, Grobmyer S, Hochwald S, Chang M, Larson B, King J.

Am J Clin Oncol. 2010 Jun;33(3):251-6. doi: 10.1097/COC.0b013e3181a650e8.

PMID:
19823074
9.

Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer.

Krishnan S, Janjan NA, Skibber JM, Rodriguez-Bigas MA, Wolff RA, Das P, Delclos ME, Chang GJ, Hoff PM, Eng C, Brown TD, Crane CH, Feig BW, Morris J, Vadhan-Raj S, Hamilton SR, Lin EH.

Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):762-71.

PMID:
17011451
10.

A phase II study of neoadjuvant chemoradiotherapy with oxaliplatin and capecitabine for rectal cancer.

Zhao L, Bai C, Shao Y, Guan M, Jia N, Xiao Y, Qiu H, Zhang F, Yang T, Zhong G, Chen S.

Cancer Lett. 2011 Nov 28;310(2):134-9. doi: 10.1016/j.canlet.2011.06.026. Epub 2011 Jul 5.

PMID:
21782322
11.

Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial.

Hofheinz RD, Wenz F, Post S, Matzdorff A, Laechelt S, Hartmann JT, Müller L, Link H, Moehler M, Kettner E, Fritz E, Hieber U, Lindemann HW, Grunewald M, Kremers S, Constantin C, Hipp M, Hartung G, Gencer D, Kienle P, Burkholder I, Hochhaus A.

Lancet Oncol. 2012 Jun;13(6):579-88. doi: 10.1016/S1470-2045(12)70116-X. Epub 2012 Apr 13.

PMID:
22503032
12.

A observational study of the efficacy and safety of capecitabine versus bolus infusional 5-fluorouracil in pre-operative chemoradiotherapy for locally advanced rectal cancer.

Chen CF, Huang MY, Huang CJ, Wu CH, Yeh YS, Tsai HL, Ma CJ, Lu CY, Chang SJ, Chen MJ, Wang JY.

Int J Colorectal Dis. 2012 Jun;27(6):727-36. doi: 10.1007/s00384-011-1377-3. Epub 2012 Jan 19.

PMID:
22258885
13.

Capecitabine initially concomitant to radiotherapy then perioperatively administered in locally advanced rectal cancer.

Zampino MG, Magni E, Leonardi MC, Petazzi E, Santoro L, Luca F, Chiappa A, Petralia G, Trovato C, Fazio N, Orecchia R, Nolè F, de Braud F.

Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):421-7. doi: 10.1016/j.ijrobp.2008.11.002. Epub 2009 Feb 11.

PMID:
19211200
14.

Prospective phase II trial of neoadjuvant chemo-radiotherapy with Oxaliplatin and Capecitabine in locally advanced rectal cancer (XELOXART).

Ricardi U, Racca P, Franco P, Munoz F, Fanchini L, Rondi N, Dongiovanni V, Gabriele P, Cassoni P, Ciuffreda L, Morino M, Filippi AR, Aglietta M, Bertetto O.

Med Oncol. 2013;30(2):581. doi: 10.1007/s12032-013-0581-0. Epub 2013 Apr 19.

PMID:
23606239
15.

Randomized phase 3 trial comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancer.

Park JH, Yoon SM, Yu CS, Kim JH, Kim TW, Kim JC.

Cancer. 2011 Aug 15;117(16):3703-12. doi: 10.1002/cncr.25943. Epub 2011 Feb 15.

16.

A phase II trial of neoadjuvant IMRT-based chemoradiotherapy followed by one cycle of capecitabine for stage II/III rectal adenocarcinoma.

Zhu J, Gu W, Lian P, Sheng W, Cai G, Shi D, Cai S, Zhang Z.

Radiat Oncol. 2013 May 29;8:130. doi: 10.1186/1748-717X-8-130.

17.

Preoperative concurrent radiotherapy with capecitabine before total mesorectal excision in locally advanced rectal cancer.

Kim JC, Kim TW, Kim JH, Yu CS, Kim HC, Chang HM, Ryu MH, Park JH, Ahn SD, Lee SW, Shin SS, Kim JS, Choi EK.

Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):346-53.

PMID:
15913913
18.

Preoperative radiotherapy combined with capecitabine chemotherapy in Chinese patients with locally advanced rectal cancer.

Jin J, Meng H, Zhou G, Xu X, Xue Z, Xu X, Wang F, Lu W, Li X, Zhang H, Deng J.

J Gastrointest Surg. 2011 Oct;15(10):1858-65. doi: 10.1007/s11605-011-1637-0. Epub 2011 Jul 28.

PMID:
21796454
19.

Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial.

Dunst J, Debus J, Rudat V, Wulf J, Budach W, Hoelscher T, Reese T, Mose S, Roedel C, Zuehlke H, Hinke A.

Strahlenther Onkol. 2008 Sep;184(9):450-6. doi: 10.1007/s00066-008-1751-4. Epub 2008 Sep 19.

PMID:
19016023
20.

Phase II study of weekly intravenous oxaliplatin combined with oral daily capecitabine and radiotherapy with biologic correlates in neoadjuvant treatment of rectal adenocarcinoma.

Fakih MG, Bullarddunn K, Yang GY, Pendyala L, Toth K, Andrews C, Rustum YM, Ross ME, Levea C, Puthillath A, Park YM, Rajput A.

Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):650-7. doi: 10.1016/j.ijrobp.2008.01.020. Epub 2008 Jun 17.

PMID:
18565686

Supplemental Content

Support Center